Topiramate Tablet, Film Coated
Product Images NDC 71335-9727

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-9727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure of topiramate, showing its molecular arrangement with rings and functional groups, including sulfonamide and ether moieties, consistent with the generic drug topiramate.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A line graph depicting cumulative rates for time to first seizure over a period of 500 days. It compares two dosing groups of topiramate, 50 mg/day (N=234) and 400 mg/day (N=236), with the x-axis labeled as time in days and the y-axis as cumulative rates for time to first seizure. The graph includes a noted p-value of 0.0002.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar graph comparing the change from baseline to double-blind phase in average monthly migraine period rate (±SE) across two studies. It displays data for placebo, topiramate 50 mg/day, topiramate 100 mg/day, and topiramate 200 mg/day groups. The graph highlights significant reductions in migraine rates with increasing topiramate doses compared to placebo.*
FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Label (Lbl713359727)

Label (Lbl713359727)
Topiramate Tablets, USP 25 mg film-coated oral tablets. The label indicates storage instructions between 20° to 25° C with permitted excursions, dispensing guidance, and child safety warnings. The package contains 30 tablets, repackaged by Bryant Ranch Prepack and manufactured by Unichem Laboratories Ltd. NDC 71335-9727-1 is shown alongside barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.